SCHEMBL8340733

SCHEMBL8340733

CN1C2CCCCC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14131169 1.00
SCHEMBL1030123 1.00 ALDH1A1 (0.41)
SCHEMBL13156428 0.96
SCHEMBL7948348 0.92
SCHEMBL12605911 0.84 CYP1A2 (0.34)
SCHEMBL12019480 0.84 CYP1A2 (0.34)
SCHEMBL2257350 0.83 ALDH1A1 (0.36)
SCHEMBL18723474 0.83 ALDH1A1 (0.36)
Trimethylammonium SCHEMBL28886744 0.83 MAPK1 (0.39)
SCHEMBL18723477 0.83 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556191-B2 Aminoquinazoline derivatives and their salts and methods of use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-01-31 US disclosed
US-20160039838-A1 AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-11 US disclosed
US-8815909-B2 Diaminocyclohexane compounds and uses thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 US disclosed
WO-2014084330-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND 協和発酵キリン株式会社 (JP) 2014-06-05 WO disclosed
US-8633251-B2 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use UNIWERSYTET JAGIELLONSKI (PL) 2014-01-21 US disclosed
US-8524722-B2 Substituted tricyclic compounds and methods of use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-09-03 US disclosed
US-20130184284-A1 DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2013-07-18 US disclosed
US-20110021493-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 US disclosed
US-7799934-B2 Intermediates (synthons) in the synthesis of pharmaceuticals such as oseltamivir and other products; treating the arizidine with the nucleophile in the presence of a biaryl phosphoric acid catalyst UNIVERSITY OF SOUTH FLORIDA (US) 2010-09-21 US disclosed
US-20090030212-A1 Enantioselective ring-opening of aziridines UNIVERSITY OF SOUTH FLORIDA OF TAMPA 2009-01-29 US disclosed
EP-0146297-B1 SUBSTITUTED TRANS-1,2-DIAMINOCYCLOHEXYL AMIDE COMPOUNDS WARNER-LAMBERT COMPANY (US) 1988-02-03 EP disclosed
US-4677122-A ANALGESICS, DIURETICS WARNER-LAMBERT COMPANY (US) 1987-06-30 US disclosed
US-4663343-A ANAGESICS, DIURETICS WARNER-LAMBERT COMPANY (US) 1987-05-05 US disclosed
US-4656182-A ANALGESICS, DIURETICS, PSYCHOTHERAPEUTIC AGENTS WARNER-LAMBERT COMPANY (US) 1987-04-07 US disclosed
US-4598087-A DIURETICS; ANALGESICS, PSYCHOTHERAPEUTICS WARNER-LAMBERT COMPANY (US) 1986-07-01 US disclosed
US-4579863-A Substituted trans-1,2-diaminocyclohexyl amide compounds WARNER-LAMBERT COMPANY (US) 1986-04-01 US disclosed
EP-0147085-A2 Substituted trans-1.2-diaminocyclohexyl amide compounds WARNER-LAMBERT COMPANY (US) 1985-07-03 EP disclosed
EP-0146297-A1 Substituted trans-1,2-diaminocyclohexyl amide compounds WARNER-LAMBERT COMPANY (US) 1985-06-26 EP disclosed
US-4173580-A Production of β-haloalkylaminosulfonyl halides BASF AKTIENGESELLSCHAFT (DE) 1979-11-06 US disclosed
US-4014931-A FROM AZIRIDINE AND SULFURYL HALIDE BASF AKTIENGESELLSCHAFT (DT) 1977-03-29 US disclosed